These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38611843)

  • 1. Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy.
    Munderere R; Gulfam M; Ali I; Kim SH; Vu TT; Park SH; Lim KT
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
    Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
    Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
    Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
    J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-loaded folic acid of solid-phase synthesis conjugated gold nanoparticles targeted treatment for rheumatoid arthritis.
    Li X; Wang H; Zou X; Su H; Li C
    Eur J Pharm Sci; 2022 Mar; 170():106101. PubMed ID: 34936935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
    Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro.
    Essa ML; Elashkar AA; Hanafy NAN; Saied EM; El-Kemary M
    Int J Biol Macromol; 2022 May; 206():467-480. PubMed ID: 35202638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles.
    Gao C; Wang M; Zhu P; Yan C
    Int J Biol Macromol; 2021 Jan; 166():71-79. PubMed ID: 33091477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles.
    Mazzotta E; De Benedittis S; Qualtieri A; Muzzalupo R
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31888000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.
    Mahalunkar S; Yadav AS; Gorain M; Pawar V; Braathen R; Weiss S; Bogen B; Gosavi SW; Kundu GC
    Int J Nanomedicine; 2019; 14():8285-8302. PubMed ID: 31802866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
    Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
    BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
    J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
    Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.